Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs.
- Published In:
- Nature communications, 16(1), 9512 (2025)
- Authors:
- Colston, Kyle J, Faivre, Kyle T, Schneebeli, Severin T
- Database ID:
- RPEP-10518
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10518APA
Colston, Kyle J; Faivre, Kyle T; Schneebeli, Severin T. (2025). Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs.. Nature communications, 16(1), 9512. https://doi.org/10.1038/s41467-025-64891-0
MLA
Colston, Kyle J, et al. "Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs.." Nature communications, 2025. https://doi.org/10.1038/s41467-025-64891-0
RethinkPeptides
RethinkPeptides Research Database. "Permeation enhancer-induced membrane defects assist the oral..." RPEP-10518. Retrieved from https://rethinkpeptides.com/research/colston-2025-permeation-enhancerinduced-membrane-defects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.